AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. TMO
  4. [Form 4] Thermo Fisher Scientific, Inc. Insider Trading Activity

[Form 4] Thermo Fisher Scientific, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

IZEA Worldwide, Inc. (ticker: IZEA) filed a Form 4 on 1 July 2025 reporting that director Daniel R. Rua received 5,882 shares of common stock on 30 June 2025. The shares represent payment of Q2 2025 director fees valued at $15,000, calculated at the closing market price of $2.55 per share on the grant date. The restricted-stock award vested immediately and was acquired at $0 cash cost. Following the grant, Rua鈥檚 direct beneficial ownership increased to 85,259 shares. No derivative securities, sales, or additional transactions were disclosed, and the filing was made under Rule 10b5-1.

IZEA Worldwide, Inc. (simbolo: IZEA) ha presentato un Modulo 4 il 1掳 luglio 2025, comunicando che il direttore Daniel R. Rua ha ricevuto 5.882 azioni ordinarie il 30 giugno 2025. Le azioni rappresentano il pagamento delle commissioni da direttore per il secondo trimestre 2025, valutate 15.000 $, calcolate al prezzo di chiusura di 2,55 $ per azione alla data di assegnazione. Il premio in azioni vincolate 猫 maturato immediatamente ed 猫 stato acquisito a un costo in contanti pari a 0 $. Dopo l鈥檃ssegnazione, la propriet脿 diretta di Rua 猫 aumentata a 85.259 azioni. Non sono stati divulgati titoli derivati, vendite o altre transazioni, e la comunicazione 猫 stata effettuata ai sensi della Regola 10b5-1.

IZEA Worldwide, Inc. (s铆mbolo: IZEA) present贸 un Formulario 4 el 1 de julio de 2025 informando que el director Daniel R. Rua 谤别肠颈产颈贸 5,882 acciones ordinarias el 30 de junio de 2025. Las acciones representan el pago de las tarifas de director del segundo trimestre de 2025 valoradas en $15,000, calculadas al precio de cierre de $2.55 por acci贸n en la fecha de concesi贸n. La asignaci贸n de acciones restringidas se hizo efectiva inmediatamente y se adquiri贸 sin costo en efectivo. Tras la concesi贸n, la propiedad directa de Rua aument贸 a 85,259 acciones. No se divulgaron valores derivados, ventas ni transacciones adicionales, y la presentaci贸n se realiz贸 bajo la Regla 10b5-1.

IZEA Worldwide, Inc. (韹办护: IZEA)電� 2025雲� 7鞗� 1鞚检棎 鞝滌稖頃� Form 4鞐愳劀 鞚挫偓 Daniel R. Rua臧� 2025雲� 6鞗� 30鞚检棎 5,882欤�鞚� 氤错喌欤茧ゼ 氚涭晿雼り碃 氤搓碃頄堨姷雼堧嫟. 鞚� 欤检嫕鞚� 2025雲� 2攵勱赴 鞚挫偓 氤挫垬搿滌劀, 攵�鞐澕 膦呹皜鞚� 欤茧嫻 $2.55毳� 旮办鞙茧 韽夑皜霅� $15,000 靸侂嫻鞛呺媹雼�. 鞝滍暅 欤检嫕 氤挫儊鞚� 歃夓嫓 旆摑霅橃棃鞙茧┌, 順勱笀 牍勳毄 0雼煬搿� 須嶋摑霅橃棃鞀惦媹雼�. 攵�鞐� 頉� Rua鞚� 歆侅爲 靻岇湢 欤检嫕鞚� 85,259欤�搿� 歃濌皜頄堨姷雼堧嫟. 韺岇儩 歃濌秾, 毵る弰 霕愲姅 於旉皜 瓯半灅電� 瓿店皽霅橃 鞎婌晿鞙茧┌, 鞝滌稖鞚� Rule 10b5-1鞐� 霐半澕 鞚措（鞏挫鞀惦媹雼�.

IZEA Worldwide, Inc. (symbole : IZEA) a d茅pos茅 un formulaire 4 le 1er juillet 2025, indiquant que le directeur Daniel R. Rua a re莽u 5 882 actions ordinaires le 30 juin 2025. Ces actions repr茅sentent le paiement des honoraires de directeur pour le deuxi猫me trimestre 2025, 茅valu茅s 脿 15 000 $, calcul茅s au cours de cl么ture de 2,55 $ par action 脿 la date d鈥檃ttribution. La remise d鈥檃ctions restreintes a 茅t茅 imm茅diatement acquise et obtenue 脿 un co没t en esp猫ces nul. Suite 脿 cette attribution, la propri茅t茅 directe de Rua est pass茅e 脿 85 259 actions. Aucune valeur d茅riv茅e, vente ou transaction suppl茅mentaire n鈥檃 茅t茅 divulgu茅e, et le d茅p么t a 茅t茅 effectu茅 conform茅ment 脿 la r猫gle 10b5-1.

IZEA Worldwide, Inc. (Ticker: IZEA) reichte am 1. Juli 2025 ein Formular 4 ein und meldete, dass der Direktor Daniel R. Rua am 30. Juni 2025 5.882 Stammaktien erhalten hat. Die Aktien stellen die Zahlung der Vorstandshonorare f眉r das zweite Quartal 2025 im Wert von 15.000 $ dar, berechnet zum Schlusskurs von 2,55 $ pro Aktie am Zuteilungsdatum. Die Restricted-Stock-Zuteilung wurde sofort f盲llig und zu einem Baraufwand von 0 $ erworben. Nach der Zuteilung erh枚hte sich Ruas direkte Beteiligung auf 85.259 Aktien. Es wurden keine derivativen Wertpapiere, Verk盲ufe oder weitere Transaktionen offengelegt, und die Meldung erfolgte gem盲脽 Regel 10b5-1.

Positive
  • Director increased ownership by ~7%, underscoring alignment with shareholders and confidence in IZEA鈥檚 prospects.
  • Cash-conserving compensation structure supports liquidity while incentivizing the board through equity exposure.
Negative
  • Minor share dilution from issuance of 5,882 new shares, though impact on total float is immaterial.

Insights

TL;DR: Routine fee-in-stock grant; marginally positive insider alignment, financially immaterial.

The acquisition is compensation, not an open-market purchase, but it still raises the director鈥檚 stake by roughly 7%, signaling continued alignment with shareholders. At $15k, the dollar value and potential dilution are negligible relative to IZEA鈥檚 market cap. Because there is no sale, the transaction avoids negative sentiment often linked to insider disposals. Overall impact on valuation or liquidity is minimal.

TL;DR: Stock-based board fees conserve cash and promote equity culture; standard governance practice.

Paying director fees in immediately-vesting stock is common among micro-caps to preserve cash while aligning board incentives. The 10b5-1 designation indicates pre-arranged, rule-compliant issuance, limiting legal risk. No unusual clauses or staggered vesting suggest straightforward governance. Investors should view this as neutral to slightly positive, reflecting prudent cash management without creating complex equity instruments.

IZEA Worldwide, Inc. (simbolo: IZEA) ha presentato un Modulo 4 il 1掳 luglio 2025, comunicando che il direttore Daniel R. Rua ha ricevuto 5.882 azioni ordinarie il 30 giugno 2025. Le azioni rappresentano il pagamento delle commissioni da direttore per il secondo trimestre 2025, valutate 15.000 $, calcolate al prezzo di chiusura di 2,55 $ per azione alla data di assegnazione. Il premio in azioni vincolate 猫 maturato immediatamente ed 猫 stato acquisito a un costo in contanti pari a 0 $. Dopo l鈥檃ssegnazione, la propriet脿 diretta di Rua 猫 aumentata a 85.259 azioni. Non sono stati divulgati titoli derivati, vendite o altre transazioni, e la comunicazione 猫 stata effettuata ai sensi della Regola 10b5-1.

IZEA Worldwide, Inc. (s铆mbolo: IZEA) present贸 un Formulario 4 el 1 de julio de 2025 informando que el director Daniel R. Rua 谤别肠颈产颈贸 5,882 acciones ordinarias el 30 de junio de 2025. Las acciones representan el pago de las tarifas de director del segundo trimestre de 2025 valoradas en $15,000, calculadas al precio de cierre de $2.55 por acci贸n en la fecha de concesi贸n. La asignaci贸n de acciones restringidas se hizo efectiva inmediatamente y se adquiri贸 sin costo en efectivo. Tras la concesi贸n, la propiedad directa de Rua aument贸 a 85,259 acciones. No se divulgaron valores derivados, ventas ni transacciones adicionales, y la presentaci贸n se realiz贸 bajo la Regla 10b5-1.

IZEA Worldwide, Inc. (韹办护: IZEA)電� 2025雲� 7鞗� 1鞚检棎 鞝滌稖頃� Form 4鞐愳劀 鞚挫偓 Daniel R. Rua臧� 2025雲� 6鞗� 30鞚检棎 5,882欤�鞚� 氤错喌欤茧ゼ 氚涭晿雼り碃 氤搓碃頄堨姷雼堧嫟. 鞚� 欤检嫕鞚� 2025雲� 2攵勱赴 鞚挫偓 氤挫垬搿滌劀, 攵�鞐澕 膦呹皜鞚� 欤茧嫻 $2.55毳� 旮办鞙茧 韽夑皜霅� $15,000 靸侂嫻鞛呺媹雼�. 鞝滍暅 欤检嫕 氤挫儊鞚� 歃夓嫓 旆摑霅橃棃鞙茧┌, 順勱笀 牍勳毄 0雼煬搿� 須嶋摑霅橃棃鞀惦媹雼�. 攵�鞐� 頉� Rua鞚� 歆侅爲 靻岇湢 欤检嫕鞚� 85,259欤�搿� 歃濌皜頄堨姷雼堧嫟. 韺岇儩 歃濌秾, 毵る弰 霕愲姅 於旉皜 瓯半灅電� 瓿店皽霅橃 鞎婌晿鞙茧┌, 鞝滌稖鞚� Rule 10b5-1鞐� 霐半澕 鞚措（鞏挫鞀惦媹雼�.

IZEA Worldwide, Inc. (symbole : IZEA) a d茅pos茅 un formulaire 4 le 1er juillet 2025, indiquant que le directeur Daniel R. Rua a re莽u 5 882 actions ordinaires le 30 juin 2025. Ces actions repr茅sentent le paiement des honoraires de directeur pour le deuxi猫me trimestre 2025, 茅valu茅s 脿 15 000 $, calcul茅s au cours de cl么ture de 2,55 $ par action 脿 la date d鈥檃ttribution. La remise d鈥檃ctions restreintes a 茅t茅 imm茅diatement acquise et obtenue 脿 un co没t en esp猫ces nul. Suite 脿 cette attribution, la propri茅t茅 directe de Rua est pass茅e 脿 85 259 actions. Aucune valeur d茅riv茅e, vente ou transaction suppl茅mentaire n鈥檃 茅t茅 divulgu茅e, et le d茅p么t a 茅t茅 effectu茅 conform茅ment 脿 la r猫gle 10b5-1.

IZEA Worldwide, Inc. (Ticker: IZEA) reichte am 1. Juli 2025 ein Formular 4 ein und meldete, dass der Direktor Daniel R. Rua am 30. Juni 2025 5.882 Stammaktien erhalten hat. Die Aktien stellen die Zahlung der Vorstandshonorare f眉r das zweite Quartal 2025 im Wert von 15.000 $ dar, berechnet zum Schlusskurs von 2,55 $ pro Aktie am Zuteilungsdatum. Die Restricted-Stock-Zuteilung wurde sofort f盲llig und zu einem Baraufwand von 0 $ erworben. Nach der Zuteilung erh枚hte sich Ruas direkte Beteiligung auf 85.259 Aktien. Es wurden keine derivativen Wertpapiere, Verk盲ufe oder weitere Transaktionen offengelegt, und die Meldung erfolgte gem盲脽 Regel 10b5-1.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
WEISLER DION J
(Last) (First) (Middle)
168 THIRD AVENUE
(Street)
WALTHAM MA 02451
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
THERMO FISHER SCIENTIFIC INC. [ TMO ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/28/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Phantom Stock Units (1) 06/28/2025 A 91.85 (2) (2) Common Stock 91.85 (2) 2,493.17 D
Explanation of Responses:
1. Convertible into Common Stock on a 1-for-1 basis.
2. Represents stock units credited to the Reporting Person's account as of June 28, 2025, at a price of $408.28 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control.
/s/ Melodie T. Morin, Attorney-in-Fact for Dion J. Weisler 07/01/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

How many IZEA shares did director Daniel Rua acquire?

He received 5,882 shares of restricted stock on 30 June 2025.

What was the value of the stock award reported in the Form 4 for IZEA?

The award was valued at $15,000, based on a $2.55 closing price.

Did the restricted stock granted to Daniel Rua vest immediately?

Yes. The filing states the award vests immediately on the grant date.

What is Daniel Rua鈥檚 total IZEA shareholding after the transaction?

After the award, he beneficially owns 85,259 shares directly.

Was any cash paid for the shares in this IZEA Form 4 filing?

No. The shares were granted at $0 cash cost as director fee compensation.

Does the filing involve any derivative securities?

No derivative securities were reported in Table II of the Form 4.
Stock TMO logo
Thermo Fishr Sci

NYSE:TMO

TMO Rankings

#68 Ranked by Market Cap
#2040 Ranked by Dividends

TMO Latest News

Jul 1, 2025
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, July 23, 2025
Jun 2, 2025
Thermo Fisher Scientific Unveils Next-generation Mass Spectrometers at ASMS 2025 to Revolutionize Biopharma Applications and Omics Research
May 21, 2025
Thermo Fisher Scientific Declares Quarterly Dividend
May 6, 2025
Thermo Fisher Scientific to Present at BofA Securities 2025 Health Care Conference on May 13
Apr 24, 2025
Thermo Fisher Scientific Invests to Enhance U.S. Innovation and Support Customers鈥� Manufacturing

TMO Latest SEC Filings

Jul 1, 2025
[Form 4] Thermo Fisher Scientific, Inc. Insider Trading Activity
Jul 1, 2025
[Form 4] Thermo Fisher Scientific, Inc. Insider Trading Activity
Jul 1, 2025
[Form 4] Thermo Fisher Scientific, Inc. Insider Trading Activity
Jul 1, 2025
[Form 4] Thermo Fisher Scientific, Inc. Insider Trading Activity

TMO Stock Data

152.65B
376.66M
0.2%
92.56%
1.1%
Diagnostics & Research
Measuring & Controlling Devices, Nec
United States
WALTHAM